Edwards Lifesciences Corporation EW
Set alert
95.41 USD +2.14 +2.30%
As of Nov 3, 12:58 PM ET
93.27 Day range 96.09
75.87 52-week range 95.44
- YTD
- +11.91%
- 1 year
- +14.85%
- Open
- 93.67
- Prev close
- 93.26
- Mkt cap
- 54.95B
- Vol
- 2.93M
- Avg vol
- 3.47M
- EPS
- 1.68
- P/E
- 56.81
- Div yield
- 0.00%
More statistics
- Low
- 93.27
- High
- 96.09
- Forward P/E
- 27.58
- Beta
- 0.83
- Short ratio
- 2.43
- Inst. own
- 95.48%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 88.14
- 200-d avg
- 85.43
- 1y target
- 101.87
3M chart
Events in this range
- Sep 11, 2026Rating: BTIG · Buy → Buy
- Oct 7, 2026Rating: Barclays · — → Overweight
Signals (15)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 19, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 16, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 15, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 14, 2026 | 2 weeks ago |
| MACD: Sell Signal | Sep 30, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 29, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 24, 2026 | 1 month ago |
| SMA: Bearish | Sep 23, 2026 | 1 month ago |
| SMA: Bullish | Sep 22, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 21, 2026 | 1 month ago |
| SMA: Bearish | Sep 17, 2026 | 1 month ago |
| SMA: Bullish | Sep 16, 2026 | 1 month ago |
| SMA: Bearish | Sep 8, 2026 | 1 month ago |
| SMA: Bearish | Sep 8, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 21, 2026 | 2 months ago |
Financial health
Altman Z-Score
13.03 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
6 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B3 / 5 overall
- DCF 3
- Return on Equity 3
- Return on Assets 4
- Debt / Equity 4
- P/E 1
- P/B 2
Valuation
P/E 46.3×
FY 2016 5y median 33.0× FY 2025
P/S 8.2×
FY 2016 5y median 8.6× FY 2025
P/B 4.8×
FY 2016 5y median 7.0× FY 2025
P/FCF 37.3×
FY 2016 5y median 57.6× FY 2025
EV/EBITDA 33.3×
FY 2016 5y median 29.8× FY 2025
EV/Sales 7.8×
FY 2016 5y median 8.6× FY 2025
FCF Yield 2.7%
FY 2016 5y median 1.7% FY 2025
Profitability
Gross Margin 78.1%
FY 2016 5y median 78.3% FY 2025
Operating Margin 27.0%
FY 2016 5y median 28.5% FY 2025
Net Margin 17.7%
FY 2016 5y median 28.3% FY 2025
ROE 10.4%
FY 2016 5y median 25.8% FY 2025
ROIC 11.4%
FY 2016 5y median 15.5% FY 2025
ROA 7.8%
FY 2016 5y median 17.7% FY 2025
Growth (YoY)
Revenue 11.5%
FY 2016 FY 2025
Operating Income 18.7%
FY 2016 FY 2025
EPS (diluted) -73.7%
FY 2016 FY 2025
Free Cash Flow 360.5%
FY 2016 FY 2025
Financial Health
Current Ratio 3.7×
FY 2016 5y median 3.4× FY 2025
Quick Ratio 3.1×
FY 2016 5y median 2.6× FY 2025
Debt / Equity 0.1×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA -1.6×
FY 2016 5y median -0.3× FY 2025
Interest Coverage 0.0×
FY 2016 5y median 65.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
